A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults
Status:
Completed
Trial end date:
2019-10-07
Target enrollment:
Participant gender:
Summary
This study is designed to assess the relative bioavailability of ABI-H2158 tablets (Test
Formulation) compared to ABI-H2158 tablets (Reference Formulation). The effect of food on the
pharmacokinetics of the Test Formulation will also be evaluated under fed and fasting
conditions.